Scientific Publications

ForeseeHome
November 2010

Long-term monitoring of age-related macular degeneration with preferential hyperacuity perimetry

Stur M, Manor Y. Long-term monitoring of age-related macular degeneration with preferential hyperacuity perimetry. Ophthalmic Surg Lasers Imaging. 2010 Nov-Dec;41(6):598-606.

FDA Intended Use

ForeseeHome has not been approved by FDA for use other than described in the following Indication for Use: The ForeseeHome is intended for use in the detection and characterization of central and paracentral metamorphopsia (visual distortion) in patients with age-related macular degeneration as an aid in monitoring progression of disease factors causing metamorphopsia including, but not limited to choroidal neovascularization (CNV). It is intended to be used at home for patients with stable fixation.

Media enquiries? Reach out to our Media Contact